Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Lebanon says Israeli strike killed 13 people near Palestinian refugee camp - 2Saucony's $125 'Comfy, Stylish' Sneakers Are Now $55
- 3The most effective method to Succeed in Your Web based Advertising Degree: Procedures for Progress
- 4Eight arrested in joint Scotland and Spain gang raids
- 5Minneapolis ICE shooting live updates: Protests continue over agent's killing of Renee Nicole Good; Walz puts National Guard on standby
- Day to day Temporary Positions That Compensate Fairly in the US
- A Manual for Pick Dependable Vehicle Rental Administrations For 2024
- Fundamental Archives for Beginning Your Business
- Very good quality Greens All over The Planet
- 4 Electric Vehicle Brands: Execution, Unwavering quality, and Development
- The Starbucks for Life game is back, along with your chance to win a 'Bearista' cold cup. Here's how to get your paws on one.
- More charges filed against ex-left-wing RAF member Daniela Klette
- Genesis Marks 10th Anniversary With Magma GT Concept Aimed at High-Performance Flagships
- We may be witnessing the messy death of a star in real time
